Changing perceptions in pulmonary hypertension.
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Christian
C
Gerges
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Electronic address: irene.lang@meduniwien.ac.at.
Irene M
IM
Lang
D000959:Antihypertensive Agents / Q000627:therapeutic use; D065128:Endothelin Receptor Antagonists / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D011668:Pulmonary Veno-Occlusive Disease / Q000235:genetics; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy; D017211:Treatment Failure; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D011720:Pyrazoles; D011743:Pyrimidines; D013449:Sulfonamides; D014665:Vasodilator Agents; C542595:riociguat; C533860:macitentan